Storage conditions
Announce -Store at 20 ℃.
Hazard statement
Announce Safety level: S22-24/25
Functional indications
Announce be used for bronchiectasia , lung abscess, etc. Usage and dosage
Announce 1. Inhalation or intracavitary injection: up to 50000 units once.
2. Intramuscular injection: 1 million units each time, once every two days.
3. The local application concentration is 1250-2500 units per milliliter. It is often used in combination with streptokinase.
Adverse reaction and attention: after injection, it may cause weakness, gastrointestinal reaction, and occasionally skin rash.
Product specification
Announce Deoxyribonuclease for injection: each tube contains 25000 units and 100000 units of this product.
Medicare or not: medical insurance
Non prescription drugs or not: prescription
Other information
Announce 1. Acute suppurative Cellulitis , bronchopleural lou Active tuberculosis Patients should not use it. 2. Do not mix with heparin, citrate, etc.
3. The solution shall be prepared before use, and the storage temperature shall not exceed 4 ℃.
